Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.
about
Megakaryocyte- and megakaryocyte precursor-related gene therapiesHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsCongenital platelet disorders and understanding of platelet function.A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?Glanzmann thrombasthenia: state of the art and future directions.In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infectionC560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortalityPlatelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A.High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia.Platelet signaling-a primer.Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.Genetic engineering of platelets to neutralize circulating tumor cellsTargeting expression to megakaryocytes and platelets by lineage-specific lentiviral vectors.Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A.
P2860
Q26770867-F88BDABB-923C-4306-9116-4238E384270BQ26859147-DD0328A9-77AC-435F-9956-A0A7D22E8FADQ33411778-05D08832-C5A2-45B4-958D-B4211AFF595DQ33416544-1EFC21D6-7A04-4F44-8DD2-6FCEC0598175Q33571529-CFF2CEC0-F213-466A-B319-3D9A1134214BQ34021880-C5DADA74-6C83-4330-9C24-F9068CB30DFCQ36986071-091AF413-EB50-4020-87CE-D27C97783DD9Q37403833-CE95C767-A791-4133-9EE3-B332CE05F5CFQ37535262-E3E41B09-9E22-49C4-A0F0-1684853F1D59Q37982455-680D5A5B-3036-4E79-B592-8EA4EF75E517Q38059249-15C801F5-96BD-4555-A3B3-A6192281E820Q38790593-84A38D11-7C31-4EE4-863D-C7C1BED17D9EQ40435211-14C08565-396A-49A1-8FA3-9D23F57043B3Q42975417-1ECEAAA2-4154-4DE6-8788-A30401440DDD
P2860
Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Platelet gene therapy improves ...... alphaIIbbeta3-deficient dogs.
@ast
Platelet gene therapy improves ...... alphaIIbbeta3-deficient dogs.
@en
type
label
Platelet gene therapy improves ...... alphaIIbbeta3-deficient dogs.
@ast
Platelet gene therapy improves ...... alphaIIbbeta3-deficient dogs.
@en
prefLabel
Platelet gene therapy improves ...... alphaIIbbeta3-deficient dogs.
@ast
Platelet gene therapy improves ...... alphaIIbbeta3-deficient dogs.
@en
P2093
P2860
P356
P1476
Platelet gene therapy improves ...... alphaIIbbeta3-deficient dogs.
@en
P2093
David A Wilcox
Eric S Jensen
Kenneth Cornetta
Mary K Boudreaux
Sevasti B Koukouritaki
Troy B Hawkins
P2860
P304
P356
10.1073/PNAS.1016394108
P407
P577
2011-05-23T00:00:00Z